Alpha 2.0
Login Register
» Authors » Thomas Hubiche

Thomas Hubiche

Explore the profile of Thomas Hubiche including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 936
Followers 0
Related Specialties
Dermatology
Pediatrics
Infectious Diseases
Top 10 Co-Authors
Pascal Del Giudice
Christine Chiaverini
Stephanie Mallet
Annabel Maruani
Franck Boralevi
Alice Phan
Juliette Miquel
Emmanuel Mahe
Juliette Mazereeuw-Hautier
Sebastien Barbarot
Published In
Acta Derm Venereol
J Am Acad Dermatol
Dermatology
J Eur Acad Dermatol Venereol
Pediatr Infect Dis J
Affiliations
Soon will be listed here.
Recent Articles
1.
Switching From Dupilumab to Tralokinumab or Janus Kinase Inhibitors in Cases of Ocular and/or Facial Adverse Events in Patients With Atopic Dermatitis: A Multicenter Retrospective Study
Beyrouti A, Deuze J, Fontas E, Foureau A, Barbarot S, Aubert H, et al.
J Allergy Clin Immunol Pract . 2024 Dec; 13(2):353-360. PMID: 39672377
Background: Patients with atopic dermatitis (AD) may discontinue dupilumab owing to dupilumab-induced ocular adverse events (DOAEs) or dupilumab-induced facial redness (DFR). Objective: To evaluate DOAE and DFR outcomes after switching...
2.
Long-term effects of sirolimus treatment for slow-flow vascular malformations: Real-world evidence from the French observational multicentre SIROLO study
Maillet C, Boccara O, Mallet S, Bessis D, Labreze C, Mary-Prey S, et al.
J Eur Acad Dermatol Venereol . 2024 Nov; PMID: 39584318
Rationale: Sirolimus is a treatment for slow-flow vascular malformations (SFVMs). However, the long-term management remains challenging. Objectives: The SIROLO study assessed the long-term effects and real-life management of oral sirolimus...
3.
Dupilumab in atopic-dermatitis-like eczema associated with inborn errors of immunity: A nationwide study
Guillemin C, Bellon N, Jachiet M, Barbarot S, Bourrat E, Chiaverini C, et al.
J Am Acad Dermatol . 2024 Sep; 92(1):165-168. PMID: 39343308
No abstract available.
4.
Efficacy of dupilumab against pruritus in dystrophic epidermolysis bullosa: Real-life data from a retrospective bicentric study
Chiaverini C, Kandemir S, Hubiche T, Bourrat E, Hovnanian A
J Eur Acad Dermatol Venereol . 2024 Sep; PMID: 39269013
No abstract available.
5.
Efficacy and tolerance of dupilumab in patients with moderate-to-severe atopic dermatitis and obesity
Dupuis J, Tauber M, Mahe E, Jachiet M, Soria A, Tetart F, et al.
J Eur Acad Dermatol Venereol . 2024 Jul; 39(2):e174-e178. PMID: 39082796
No abstract available.
6.
Management of scabies in children under 15 kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology
Morand A, Weill A, Miquel J, Chosidow O, Guillot B, Tannous J, et al.
Br J Dermatol . 2024 Jul; 191(6):1014-1016. PMID: 39028660
No abstract available.
7.
Multifocal tuberculosis: a phenotype of Mendelian susceptibility to mycobacterial disease
Gourdan P, Colanic I, Blanc S, Fina A, Baque-Juston M, Solla F, et al.
Arch Dis Child . 2024 May; 109(8):673. PMID: 38740434
No abstract available.
8.
Erythema Migrans Caused by Borrelia spielmanii, France
Del Giudice P, Freychet F, Kopec L, Fenollar F, Eldin C, Velin M, et al.
Emerg Infect Dis . 2023 Oct; 29(11):2366-2369. PMID: 37877610
We describe a rare case of early Lyme borreliosis in France caused by Borrelia spielmanii, which manifested as a large erythema chronicum migrans rash. The patient completely recovered after a...
9.
Parsnips and Phytophotodermatitis
Chene L, Chiaverini C, Kandemir S, Hubiche T
J Pediatr . 2023 Sep; 264:113727. PMID: 37696389
No abstract available.
10.
Ischemic cerebral stroke risk under psoriasis and psoriatic arthritis treatment: A real-world observational study from the French national healthcare system database
Bulsei J, Fontas E, Hubiche T, Passeron T
J Eur Acad Dermatol Venereol . 2023 Jul; 37(12):e1447-e1448. PMID: 37458687
No abstract available.